Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Kasper

Showing results (411-420 of 419) with videos related to

Pageof 42
Sort By:
You have reached the last page of results.This site can display upto 419 results.
ESMO Open|July 12, 2024
Dermatology-related quality-of-life outcomes in patients with RAS wild-type metastatic colorectal cancer treated with fluorouracil and folinic acid with or without panitumumab (Pmab) maintenance after FOLFOX + Pmab induction: a prespecified secondary analysis of the phase II randomized PanaMa (AIO KRK 0212) trialA Ballhausen, M Karthaus, S Fruehauf, et al.
Journal of Cancer Research and Clinical Oncology|November 5, 2022
A prognostic systemic inflammation score (SIS) in patients with advanced intrahepatic cholangiocarcinomaM Maßmann, J Treckmann, P Markus, et al.
ESMO Open|February 22, 2025
Quality-adjusted survival in patients with metastatic colorectal cancer treated with fruquintinib plus best supportive care: results from FRESCO-2S Stintzing, J Tabernero, T Satoh, et al.
ESMO Gastrointestinal Oncology|February 6, 2026
TROPHIT1-a randomized, open-label, multicenter, phase II/III trial of sacituzumab govitecan compared to standard of care in metastatic colorectal cancer patientsB C Köhler, G M Haag, L Le Cornet, et al.
ESMO Open|July 17, 2024
Understanding homologous recombination repair deficiency in biliary tract cancers: clinical implications and correlation with platinum sensitivityI-A Mavroeidi, J Burghofer, S Kalbourtzis, et al.
ESMO Open|January 9, 2024
Prognostic value of deep learning-derived body composition in advanced pancreatic cancer-a retrospective multicenter studyJ Keyl, A Bucher, F Jungmann, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 19, 2022
Durvalumab with or without tremelimumab versus the EXTREME regimen as first-line treatment for recurrent or metastatic squamous cell carcinoma of the head and neck: KESTREL, a randomized, open-label, phase III studyA Psyrri, J Fayette, K Harrington, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|November 20, 2018
Updated European Consensus Statement on diagnosis and treatment of adult ADHDJ J S Kooij, D Bijlenga, L Salerno, et al.
Imaging Neuroscience (Cambridge, Mass.)|August 13, 2025
The coming decade of digital brain research: A vision for neuroscience at the intersection of technology and computingKatrin Amunts, Markus Axer, Swati Banerjee, et al.
Pageof 42

Showing results (411-420 of 419) with videos related to

Sort By:
Pageof 42
You have reached the last page of results.This site can display upto 419 results.
ESMO Open|July 12, 2024
Dermatology-related quality-of-life outcomes in patients with RAS wild-type metastatic colorectal cancer treated with fluorouracil and folinic acid with or without panitumumab (Pmab) maintenance after FOLFOX + Pmab induction: a prespecified secondary analysis of the phase II randomized PanaMa (AIO KRK 0212) trialA Ballhausen, M Karthaus, S Fruehauf, et al.
Journal of Cancer Research and Clinical Oncology|November 5, 2022
A prognostic systemic inflammation score (SIS) in patients with advanced intrahepatic cholangiocarcinomaM Maßmann, J Treckmann, P Markus, et al.
ESMO Open|February 22, 2025
Quality-adjusted survival in patients with metastatic colorectal cancer treated with fruquintinib plus best supportive care: results from FRESCO-2S Stintzing, J Tabernero, T Satoh, et al.
ESMO Gastrointestinal Oncology|February 6, 2026
TROPHIT1-a randomized, open-label, multicenter, phase II/III trial of sacituzumab govitecan compared to standard of care in metastatic colorectal cancer patientsB C Köhler, G M Haag, L Le Cornet, et al.
ESMO Open|July 17, 2024
Understanding homologous recombination repair deficiency in biliary tract cancers: clinical implications and correlation with platinum sensitivityI-A Mavroeidi, J Burghofer, S Kalbourtzis, et al.
ESMO Open|January 9, 2024
Prognostic value of deep learning-derived body composition in advanced pancreatic cancer-a retrospective multicenter studyJ Keyl, A Bucher, F Jungmann, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 19, 2022
Durvalumab with or without tremelimumab versus the EXTREME regimen as first-line treatment for recurrent or metastatic squamous cell carcinoma of the head and neck: KESTREL, a randomized, open-label, phase III studyA Psyrri, J Fayette, K Harrington, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|November 20, 2018
Updated European Consensus Statement on diagnosis and treatment of adult ADHDJ J S Kooij, D Bijlenga, L Salerno, et al.
Imaging Neuroscience (Cambridge, Mass.)|August 13, 2025
The coming decade of digital brain research: A vision for neuroscience at the intersection of technology and computingKatrin Amunts, Markus Axer, Swati Banerjee, et al.
Pageof 42